Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

CA74143C1068
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00DYKFCQ8
PREV
PreveCeutical Medical Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
PreveCeutical Medical Inc.
ISIN
CA74143C1068
TICKER
PREV
MIC
XCNQ
REUTERS
PREV.CD
BLOOMBERG
PREV CN
Tue, 04.08.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated July 27, 2026, June 12, 2026, May 12, 2026 and April 22, 2026 (the "Prior News Releases"), it has closed a fo...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Mon, 27.07.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated June 12, 2026, May 12, 2026 and April 22, 2026, it has closed a third tranche (the "Third Tranche") of its pre...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Fri, 12.06.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has closed a second tranche (the "Second Tranche") of its previously annou...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Mon, 08.06.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, today announced that BioGene Therapeutics Inc. (the "Com...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Wed, 20.05.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has extended the closing of its private non-brokered private placement (the...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news release dated April 22, 2026, it has closed an initial tranche (the "Initial Tranche") of its previously announced $1,000,000...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Preveceutical Medical
CA74143C1068

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 40,0...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.04.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected to rely on Coordinated Blanket Order 51-933 and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-93 allows eligible ventu...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Mon, 30.03.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce the appointmen...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Thu, 12.03.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H0) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, today announced that BioGene Therapeutics Inc. (the "Co...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Wed, 25.02.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that the Canadian Patent Office has allowed Canadian Patent Application No. 3127020, titled "A Cyclic Peptide", which relates to the Company's pain...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Mon, 09.02.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it has filed an International (PCT) patent application on February 5, 2026, having the application no. PCT/US2026/014110, and entitled "Delivery...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.12.2025       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical")  is pleased to announce that the Australian Patent Office has granted Australian Patent No. AU2020212659, titled "A Cyclic Peptide", which relates to the Company's pai...
Read more
Preveceutical Medical
Technical Analysis Termsheets Terminal
Permalink